- Home
- ALLE vs ARWR Comparison
ALLE vs ARWR Comparison
Compare ALLE & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLE | ARWR |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 12.4B |
| IPO Year | 2013 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ALLE | ARWR |
|---|---|---|
| Price | $151.43 | $62.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $178.00 | $107.23 |
| AVG Volume (30 Days) | 883.3K | ★ 2.0M |
| Earning Date | 10-22-2026 | 11-24-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | 9.09 | ★ 99.80 |
| EPS | ★ 3.74 | N/A |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $8.41 | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | $40.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $125.00 | $34.61 |
| 52 Week High | $183.11 | $95.49 |
Technical Indicators
Market Signals| Indicator | ALLE | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 32.23 |
| Support Level | $139.95 | $60.87 |
| Resistance Level | $156.62 | $66.37 |
| Average True Range (ATR) | 3.34 | 2.41 |
| MACD | -0.28 | 0.03 |
| Stochastic Oscillator | 63.97 | 25.44 |
Price Performance
Historical ComparisonAbout ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.